These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26546377)

  • 41. Diagnostic accuracy of the Coopscore
    Taibi L; Boyd A; Bosselut N; Bottero J; Guéchot J; Lacombe K; Lasnier E; Baudin B; Vaubourdolle M
    Ann Clin Biochem; 2018 Mar; 55(2):236-243. PubMed ID: 28661201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.
    Colin JF; Cazals-Hatem D; Loriot MA; Martinot-Peignoux M; Pham BN; Auperin A; Degott C; Benhamou JP; Erlinger S; Valla D; Marcellin P
    Hepatology; 1999 Apr; 29(4):1306-10. PubMed ID: 10094979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
    Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis].
    Park SY; Kang KH; Park JH; Lee JH; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
    Korean J Gastroenterol; 2004 Apr; 43(4):246-51. PubMed ID: 15100488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
    Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
    Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus.
    Lacombe K; Boyd A; Desvarieux M; Serfaty L; Bonnord P; Gozlan J; Molina JM; Miailhes P; Lascoux-Combe C; Gault E; Girard PM
    AIDS; 2007 Nov; 21(18):2546-9. PubMed ID: 18025897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
    Zhou J; Deng Y; Yan L; Zhao H; Wang G;
    Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.
    Lee HW; Kang W; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park YN; Han KH
    Liver Int; 2016 Jan; 36(1):24-30. PubMed ID: 25966326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
    Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
    J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gamma-glutamyl transpeptidase-platelet ratio, systemic immune inflammation index, and system inflammation response index in invasive Aspergillosis.
    Çakır N; Koc AN
    Rev Assoc Med Bras (1992); 2021 Jul; 67(7):1021-1025. PubMed ID: 34817517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model.
    Zeng MD; Lu LG; Mao YM; Qiu DK; Li JQ; Wan MB; Chen CW; Wang JY; Cai X; Gao CF; Zhou XQ
    Hepatology; 2005 Dec; 42(6):1437-45. PubMed ID: 16317674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides.
    Wendum D; Lacombe K; Chevallier M; Callard P; Valet F; Miailhes P; Bonnard P; Molina JM; Lascoux-Combe C; Fléjou JF; Girard PM
    J Clin Pathol; 2009 Apr; 62(4):361-3. PubMed ID: 19126564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets' increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis.
    Wang L; Wang B; You H; Wu X; Zhou J; Ou X; Jia J
    Hepatol Int; 2018 May; 12(3):237-243. PubMed ID: 29700765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.
    Hsu CS; Liu WL; Chao YC; Lin HH; Tseng TC; Wang CC; Chen DS; Kao JH
    Hepatol Int; 2015 Apr; 9(2):231-42. PubMed ID: 25788201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B.
    Sanai FM; Farah T; Albeladi K; Batwa F; Dahlan Y; Babatin MA; Al-Ashgar H; AlMana H; Alsaad KS; AlSwat K; Aljumah A; AlTraif IH; Kailani BE; Bzeizi KI
    BMC Gastroenterol; 2017 Aug; 17(1):101. PubMed ID: 28841822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.
    Lacombe K; Massari V; Girard PM; Serfaty L; Gozlan J; Pialoux G; Mialhes P; Molina JM; Lascoux-Combe C; Wendum D; Carrat F; Zoulim F
    AIDS; 2006 Feb; 20(3):419-27. PubMed ID: 16439876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.